Uptake and metabolism of ginsenoside Rh2 and its aglycon protopanaxadiol by Caco-2 cells

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 2, 2005, Pages 383-386

  Xie, Hai Tang ^a   Wang, Guang Ji ^a   Chen, Miao ^a   Jiang, Xi Iing ^a   Li, Hao ^a   Lv, Hua ^a   Huang, Chen Rong ^a   Wang, Rui ^a   Roberts, Michael ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Caco 2 cell; Ginsenoside Rh2; High performance liquid chromatographymass spectrometry (HPLC MS); Metabolism; Protopanaxadiol; Uptake

Indexed keywords

2,4 DINITROPHENOL; CYCLOSPORIN; DIGITOXIN; GINSENOSIDE; GINSENOSIDE RH 2; GLYCOPROTEIN P; PROTOPANAXADIOL; SODIUM AZIDE; UNCLASSIFIED DRUG; VERAPAMIL; SAPOGENIN; TRITERPENE;

ACTIVE TRANSPORT; ARTICLE; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG METABOLISM; DRUG UPTAKE; ENERGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTESTINE; KINETICS; MASS SPECTROMETRY; PH; TEMPERATURE; CHEMISTRY; METABOLISM;

CACO-2 CELLS; GINSENOSIDES; HUMANS; SAPOGENINS; TRITERPENES;

EID: 19444370594     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.383     Document Type: Article

References (11)

1. Kiefer D., Pantuso T., Am. Fam. Physician, 68, 1539-1542 (2003).
2. Lee K. Y., Park J. A., Chung E., Lee Y. H., Kim S. I., Lee S. K., Cancer Lett., 110, 93-200 (1996).
3. Park E. K., Choo M. K., Kim E. J., Biol. Pharm. Bull., 26, 1581-1584 (2003).
4. Bae E. A., Han M. J., Choo M. K., Biol. Pharm. Bull., 25, 58-63 (2002).
5. Ota T., Maeda M., Odashima S., J. Pharm. Sci., 80, 1141-1146 (1991).
6. Meunier V., Bourrie M., Berger Y., Fabre G., Cell Biol. Toxicol., 11, 187-194 (1995).
7. Dantzig A. H., Bergin L., Biochim. Biophys. Acta, 1027, 211-217 (1990).
8. Pan G. Y., Wang G. J., Liu X. D., Fawcett J. P., Xie Y. Y., Pharmacol. Toxicol., 91, 193-197 (2002).
9. Ramond M. J., Martinot-Peignoux M., Erlinger S., Biol. Cell., 54, 89-92 (1985).
10. Wacher V. J., Salphati L., Benet L. Z., Adv. Drug Deliv. Rev., 46, 89-102 (2001).
11. Efferth T., Davey M., Olbrich A., Rucker G., Gebhart E., Davey R., Blood Cells Mol. Dis., 28, 160-168 (2002).